Call For A Senate Finance Committee Hearings On Statin Side Effects
CategoriesThis and Health Supreme blogs have already had 100s and continue to, just about daily, get comments regarding major side effects from Statin drugs. Many are ready to join a class action against the drug makers. See:
Lawsuits Filed Over Lipitor Side Effects
Class Action - Statins Increases Heart Disease By 10% In Women
Frequently Asked Questions About Statins
Here is another action anyone in the U.S. can do, as suggested by Duane "Space Doc" Graveline, who has collected much information about statin drugs on his website and has written a book: Statin Drug Side Effects
The action: Write to the members of the Senate Finance Committee explaining that statin drugs such as Lipitor do not help the U.S economy at all. You can put some of your own experiences in that letter, for a general outline, see the sample text blow. You should of course suitably amend it, leave out parts you don't care about and add in what you yourself think is of importance, before sending it off to your Senator or Senators.
For a listing of the members of the Senate Finance Committee, go to this site.
Chris Gupta
---------------------
NEED FOR SENATE FINANCE COMMITTEE HEARINGS
I write to address an important issue involving not only the health of millions of Americans, but also the unnecessary and increasing expenditure of billions of dollars by the U.S. Government, insurers/health and welfare funds, employers, and individuals and to request action on the part of the Senate Finance Committee.
Without regard to the actual benefit (or lack thereof) and side effects they cause, cholesterol lowering prescription drugs, also known as statins, have become hugely popular and the best selling drug for pharmaceutical companies. Statin brand names include Lipitor (manufactured by Pfizer), Zocor (Merck), Crestor (Astra Zeneca), Mevacor (Merck), Pravachol (Bristol Myers Squibb), and Lescol (Novartis). Lipitor is expected to make Pfizer $13 billion in revenues in 2006 alone. Medicare and Medicaid pay for more than half of the statins sold.It is becoming increasingly apparent that the pharmaceutical industry has been funding and manipulating drug studies and trials for the purpose of generating favorable results. This is no exception in the case of statins. Not only does the industry manipulate studies and trials, but they also manipulate reports made to the public suppressing vital information that is not to their liking and publishing only favorable findings. Drug companies also pay outside marketing and sales firms, physicians and other consultants to promote statins to the unsuspecting public. We now are learning that statins cause dangerous and permanent side effects including memory loss, amnesia, neuropathy and depression, among others. None of these side effects are included in the statin manufacturers’ warnings.
In addition, many statin manufacturers illegally promote statins to doctors, patients, Medicare and Medicaid, and third party payors through off-label marketing. Pfizer’s off-label marketing scheme for Lipitor, for example, involves the misrepresentation of treatment guidelines so that a much larger population than necessary thinks the drug is necessary for them to lower their cholesterol. The result of the off-label marketing is that the U.S. Government and others pay substantially more money for more people to receive the drug and in larger doses. Drug manufacturers understand the importance of marketing drugs. Indeed, drug companies spend about 2.5 times as much on marketing than research and development.
The effect of statins on the federal government is huge. Aside from the fact that the majority of the money spent on statins is paid by the U.S. Government, a significant number of persons taking statins suffer from side effects that result in additional medicines being paid for by the U.S. Government such as pain killers and anti-depressants. In addition, many statin users have to stop working due to their side effects and are placed on disability – an additional cost to the U.S. Government, insurers and employers.
I, consequently, urge the Senate Finance Committee to hold hearings to thoroughly explore the testing, marketing, use and side effects of the cholesterol-lowering drugs.
Date: ________, 2006
Name:___________________________
Address:___________________________
__________________________The above is attached as a word document here.
posted by Chris Gupta on Tuesday September 12 2006
updated on Thursday January 4 2007URL of this article:
http://www.newmediaexplorer.org/chris/2006/09/12/call_for_a_senate_finance_committee_hearings_on_statin_side_effects.htm
Related ArticlesThe Truth About Hyperbaric Therapy
The Quebec Public Health Insurance System should already cover the fees for Hyperbaric Treatments since summer 2000, but the medical authorities have manipulated the results and conclusions of the study, lied to parents, bypassed the honest researchers and competent doctors , lied in the Quebec medias, even going as far as changing the title and conclusions of the original article as published in the prestigious medical journal ''The Lancet'' in... [read more]
May 05, 2005 - Chris GuptaLondon Slow Food Festival
The slow food is intimately related to the organic food movement - Thought I should alert all London Ontario Canada readers about this upcoming festival. Any one interested in nutritional matters should take every opportunity to support these types of activities. Supporting of the local and regional producers of fruits and vegetables, meats, wines, beer and other beverages is the best way to ensure freshness and influence the movement to... [read more]
October 04, 2004 - Chris GuptaLegalizing the Loss of Freedoms in Canada
..."the government stacked the deck by sending it to the Transport committee instead of Legal and Constitutional Affairs where it belongs, but would have a much rougher ride."... Historically this is a common trick to pass unpopular legislation... We are to take it that the crooks that run the government are trust worthy and there is no need for concern... Gee, if that was the case, then why on earth... [read more]
April 11, 2004 - Chris Gupta
